Third Circuit Tightens "Original Source" Requirement for Whistleblowers

Back in 2003 Karl Schumann filed a whistleblower suit alleging that as an executive with benefits company Medco, he learned that Bristol-Myers Squibb and AstraZeneca paid kickbacks to Medco to buy and recommend brand name drugs. The federal government investigated for six years and decided not to participate.



http://ift.tt/1ym1Z1F